TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,184,000 | -27.9% | 46,000 | -28.3% | 0.02% | -29.4% |
| Q2 2017 | $7,194,000 | -17.3% | 64,200 | -13.9% | 0.03% | -20.9% |
| Q1 2017 | $8,700,000 | -8.0% | 74,600 | -16.9% | 0.04% | -4.4% |
| Q4 2016 | $9,453,000 | +12.8% | 89,800 | +18.5% | 0.04% | 0.0% |
| Q3 2016 | $8,377,000 | -10.9% | 75,800 | +17.3% | 0.04% | -19.6% |
| Q2 2016 | $9,406,000 | +96.0% | 64,600 | +92.8% | 0.06% | +60.0% |
| Q1 2016 | $4,798,000 | +41.8% | 33,500 | +53.0% | 0.04% | +45.8% |
| Q4 2015 | $3,384,000 | – | 21,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |